Vaccination as Immunotherapy in Hematologic Malignancies-Reference-Cited by-同舟云学术

Vaccination as Immunotherapy in Hematologic Malignancies

Published:2021-02-10 Issue:5 Volume:39 Page:433-443
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Liegel Jessica¹,Weinstock Matthew¹,Rosenblatt Jacalyn¹,Avigan David¹

Affiliation:

1. Beth Israel Deaconess Medical Center, Department of Medicine, Division of Hematology and Hematologic Malignancies, Harvard Medical School, Boston, MA

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.20.01706

Reference74 articles.

1. Immune editing shapes the cancer landscape

2. Fundamental Mechanisms of Immune Checkpoint Blockade Therapy

3. A neoantigen fitness model predicts tumour response to checkpoint blockade immunotherapy

4. Translating anti-CD19 CAR T-cell therapy into clinical practice for relapsed/refractory diffuse large B-cell lymphoma

5. Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dendritic cell vaccines extend CAR T‐cell persistence and improve the efficacy of CD19 CAR T‐cell therapy in refractory or relapsed adult B‐ALL patients;American Journal of Hematology;2024-05-07

2. Randomized Phase II Trial of Dendritic Cell/Myeloma Fusion Vaccine with Lenalidomide Maintenance after Upfront Autologous Hematopoietic Cell Transplantation for Multiple Myeloma: BMT CTN 1401;Clinical Cancer Research;2023-08-02

3. Immune Reconstitution and Vaccinations in Multiple Myeloma: A Report From the 19th International Myeloma Society Annual Workshop;Clinical Lymphoma Myeloma and Leukemia;2023-06

4. Cellular and Vaccine-Based Immunotherapy for Hematologic Malignancies;Interdisciplinary Cancer Research;2023

5. On the continuous (R)evolution of antibody-based and CAR T cell therapies in multiple myeloma: an early 2022 glance into the future;Expert Opinion on Pharmacotherapy;2022-08-10